Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Methotrexate plus prednisolone had the fewest serious side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Cyclosporine effectively treated a woman's stubborn skin condition.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Clofazimine effectively treated ashy dermatosis in a patient.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.